Unassociated Document
SEC FILE NUMBER
001-09727

CUSIP NUMBER
70322H 106


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one): 
o Form N-SAR  oForm N-CSR
  
For Period Ended: September 30, 2010
    

o      Transition Report on Form 10-K
o      Transition Report on Form 20-F
o      Transition Report on Form 11-K
o      Transition Report on Form 10-Q
o      Transition Report on Form N-SAR
 
For the Transition Period Ended: _________________________
  

 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification
 relates:_________________________________________


PART I
REGISTRANT INFORMATION

PATIENT SAFETY TECHNOLOGIES, INC.
Full Name of Registrant


 Former Name if Applicable

TWO VENTURE PLAZA, SUITE 350
Address of Principal Executive Office (Street and Number)

IRVINE, CA 92618                                 
City, State and Zip Code

 
 
 
 
PART II
RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate.)

 
x
 (a)
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 
PART III
NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Our quarterly report on Form 10-Q for the quarterly period ended September 30, 2010 cannot be filed within the prescribed time period without unreasonable expense or delay as the transition to our new Chief Financial Officer hired shortly before the due date for the third quarter Form 10-Q required additional time to ensure technical issues were properly accounted for and to ensure adequate disclosure of certain information required to be included in the Form 10-Q.

PART IV
OTHER INFORMATION

(1)           Name and telephone number of person to contact in regard to this notification
 
DAVID C. DREYER, CPA 949 387-2277
(Name) (Area Code) (Telephone Number)
 
(2)           Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).
Yes x   No o

(3)           Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes x  No o

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The following estimates are provided with respect to the third quarter 2010.

Revenue: $4.1 million, which included $2.5 million of sales shipped to Cardinal Health, our distributor, as a part of the First Forward Order.

Gross profit: $2.2 million.

Operating expenses: $1.2 million.  

As a result, the Company estimates that it will report operating income of $925 thousand.

The Company is not able to able to provide definitive estimates of other operational measures until the Company completes its preparation and review of the financial statements and related disclosures that need to be included in the Form 10−Q.



Patient Safety Technologies, Inc.
 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 Date 11/15/2010 By  /s/ David C. Dreyer                                              
  David C. Dreyer, Chief Financial Office